v3.25.2
Unaudited Condensed Consolidated Balance Sheets - USD ($)
Jun. 30, 2025
May 31, 2025
Dec. 31, 2024
May 31, 2024
Dec. 31, 2023
Current assets:          
Cash $ 2,756,894   $ 874,238   $ 2,005,351
Accounts receivable       47,709
Other receivables and prepayments 248,846   85,316   422,071
Total current assets 3,005,740   959,554   2,476,092
Property and equipment, net     1,663,926
Operating lease right-of-use assets, net       182,057
Long-term investments 15,098,846   15,098,846   16,098,846
Intangible assets       147,347
Long-term deposits   71,823   71,823
Total Assets 18,104,586   16,130,223   20,640,091
Current liabilities:          
Amounts due to related parties 79,700   79,644   79,180
Accounts payable and accrued expenses 850,750   918,611   1,894,341
Operating lease liabilities, current 76,992   102,225   125,232
Total current liabilities 1,007,442   4,338,980   2,098,753
Operating lease liabilities, non-current   14,182   99,485
Convertible notes to a related party, non-current 3,328,500      
Total Liabilities 4,335,942   4,353,162   5,256,738
Commitments and contingencies    
EQUITY          
Additional paid-in capital 96,174,010   93,474,825   93,018,528
Accumulated other comprehensive loss (income) (169,160)   89,162   (10,623)
Accumulated deficit (72,871,308)   (72,429,528)   (68,161,722)
Total stockholders’ deficit 23,133,612   21,134,514   24,846,236
Non-controlling interests (9,364,968)   (9,357,453)   (9,462,883)
Total equity 13,768,644   11,777,061   15,383,353
Total Liabilities and Equity 18,104,586   16,130,223   20,640,091
Related Party          
Current assets:          
Amounts due from related parties, net     961
Current liabilities:          
Amounts due to related parties 79,700   79,644    
Convertible notes to a related party   3,238,500  
Convertible notes to a related party, non-current       3,058,500
DiamiR Biosciences Corp          
Current assets:          
Cash   $ 56,836   $ 70,276  
Accounts receivable     89,281  
Other receivables and prepayments   46,649   120,139  
Total current assets   103,485   279,696  
Property and equipment, net   20,029   40,857  
Operating lease right-of-use assets, net   63,349   61,519  
Intangible assets   197,761   197,761  
Total Assets   384,624   579,833  
Current liabilities:          
Accounts payable and accrued expenses   231,858   148,648  
Operating lease liabilities, current   41,383   40,178  
Deferred revenue   43,982    
Total current liabilities   317,223   188,826  
Convertible notes payable to founder   957,662   614,182  
Operating lease liabilities, non-current   22,698   22,036  
Income taxes payable   176,002   159,519  
Total Liabilities   1,473,585   984,563  
Commitments and contingencies      
Stockholders’ deficit          
Preferred stock, $0.001 par value; 10,000,000 shares authorized; none issued or outstanding      
EQUITY          
Ordinary shares, value   4,441   4,441  
Additional paid-in capital   4,729,169   4,670,165  
Accumulated deficit   (5,822,571)   (5,079,336)  
Total stockholders’ deficit   (1,088,961)   (404,730)  
Total equity   (1,088,961)   (404,730)  
Total Liabilities and Equity   $ 384,624   $ 579,833  
Class A Ordinary Shares          
EQUITY          
Ordinary shares, value 52   37   31
Class B Ordinary Shares          
EQUITY          
Ordinary shares, value $ 18   $ 18   $ 22